Cirrhosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Physicians registered with the survey panel managed by Cross Marketing Inc. who have provided informed consent to participate in this survey. In addition, eligible participants are physicians who routinely manage patients with liver cirrhosis in their daily clinical practice.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The following items will be explored descriptively in this survey. 1.Clinical backgrounds of respondents and routine clinical practice for liver cirrhosis 2.Awareness of nutritional therapy and relevant clinical guidelines 3.Current practices of nutritional and sarcopenia assessments 4.Current practices of dietary therapy, including divided meals and late evening snack (LES) 5.Prescribing practices of BCAA granules and enteral nutritional formulas for hepatic failure 6.Status of nutritional management systems and collaboration with dietitians | — |
Countries
Japan
Contacts
EA Pharma Co., Ltd. Medical Science Group, Medical Dept.